Hengrui Pharmaceuticals declared a dividend of RMB 2.0 per 10 shares for FY2024, totaling RMB 127,413.02 million, with an entitlement date of May 23, 2025.
Dividend declarations are a direct return of value to shareholders, signaling financial health and management's confidence in future earnings. This announcement provides investors with concrete information regarding expected cash flows, influencing investment decisions and stock valuation. The consistent dividend payout history also reflects a stable financial strategy and commitment to shareholder returns, which can enhance investor confidence in Hengrui Pharmaceuticals' long-term prospects.
Hengrui Pharmaceuticals declared RMB 2.0 dividend per 10 shares for FY2024.
Entitlement date for the dividend is May 23, 2025.
Total cash bonus for FY2024 dividend is RMB 127,413.02 million.
As a major pharmaceutical company in China, Hengrui Pharmaceuticals' dividend policy is closely watched by domestic and international investors interested in the Chinese healthcare market. The dividend payout reflects the company's financial performance and its contribution to the Chinese economy through shareholder returns.
Total cash bonus for FY2024 dividend is RMB 127,413.02 million.
Dividend payout reinforces company's commitment to shareholder returns.
Sign in to save notes on signals.
Sign In